Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Substitute to SB440 adds behind‑the‑counter ivermectin provision, credentialing deadlines and parity review panel
Summary
Chairman Newton said the SB440 substitute removes several obsolete advisory boards, allows certain FDA‑approved ivermectin finished-dose formulations to be dispensed behind the counter under pharmacist oversight, directs DCH to create a standardized credentialing form by July 1, 2027, and establishes a behavioral‑health parity compliance review panel involving the insurance commissioner.
Chairman Newton summarized the substitute to Senate Bill 440 (LC60375S) as a department bill that eliminates outdated advisory boards and pilot programs and transfers duties when appropriate. He outlined several substantive additions: an ivermectin provision that would allow certain finished‑dose, FDA‑approved topical or other formulations to be made available behind the pharmacy counter…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
